Evolus, Inc. (EOLS) Social Stream
EVOLUS INC (EOLS) Price Targets From Analysts
Use the tables below to see what analysts covering EVOLUS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-13 | 7 | $20 | $7 | $15.142 | $9.895 | 53.03% |
| 2022-01-27 | 6 | $20 | $7 | $15.142 | $9.895 | 53.03% |
| 2022-03-04 | 7 | $20 | $7 | $15.142 | $9.895 | 53.03% |
| 2022-04-21 | 7 | $20 | $7 | $15.428 | $9.895 | 55.92% |
| 2022-04-28 | 7 | $20 | $8 | $15.571 | $9.895 | 57.36% |
| 2022-05-11 | 6 | $20 | $8 | $16 | $9.895 | 61.7% |
| 2022-05-12 | 6 | $20 | $10 | $16.333 | $9.895 | 65.06% |
| 2022-10-13 | 7 | $20 | $10 | $16.571 | $9.895 | 67.47% |
| 2022-11-02 | 6 | $20 | $10 | $16.428 | $9.895 | 66.02% |
| 2022-11-09 | 7 | $20 | $10 | $16.428 | $9.895 | 66.02% |
| 2023-03-09 | 7 | $20 | $10 | $16.714 | $9.895 | 68.91% |
| 2023-05-09 | 8 | $20 | $10 | $16.75 | $9.895 | 69.28% |
| 2023-05-10 | 8 | $25 | $14 | $19.142 | $9.895 | 93.45% |
| 2023-05-26 | 7 | $25 | $16 | $19.714 | $9.895 | 99.23% |
| 2023-06-08 | 7 | $25 | $16 | $20.142 | $9.895 | 103.56% |
| 2023-07-23 | 6 | $25 | $16 | $20.5 | $9.895 | 107.18% |
| 2023-08-03 | 6 | $27 | $20 | $22.333 | $9.895 | 125.7% |
| 2023-11-08 | 5 | $27 | $20 | $23.5 | $9.895 | 137.49% |
The Trend in the Analyst Price Target
EOLS's average price target has moved up $6.23 over the prior 15 months.
Over the past 42 weeks, EOLS's average upside potential has been 124.66%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-19 | 7 | 20 | 10 | 16.714 | 10.52 | 58.88% |
| 2023-06-08 | 6 | 25 | 16 | 20.500 | 8.58 | 138.93% |
| 2023-06-08 | 6 | 25 | 16 | 20.142 | 8.58 | 134.76% |
| 2023-07-06 | 6 | 25 | 16 | 20.500 | 7.17 | 185.91% |
| 2023-11-08 | 5 | 27 | 20 | 22.800 | 8.74 | 160.87% |
EOLS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.2 | 4 | 1 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
EOLS's average broker recommendation rating improved by 0.55 over the prior 41 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how EVOLUS INC fares relative to all US stocks, note that its average analyst price target is greater than 506.95% of that group.
- In the context of all US stocks, EVOLUS INC's upside potential (average analyst target price relative to current price) is greater than 1664.96% of them.
- In terms of how EVOLUS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1422.78% of that group.
- In terms of how EVOLUS INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 1736.18% of that group.
In the Pharmaceutical Products industry, ACET, KZIA, and VYNE are the three stocks most similar to EVOLUS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for EOLS? Use POWR Ratings for clearer insight into price direction.